Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hakima, Hannachi"'
Autor:
Annaswamy Raji, Hakima Hannachi, Annpey Pong, Steven G. Terra, Jie Liu, Steven B. Heymsfield, Silvina Gallo
Publikováno v:
Obesity (Silver Spring, Md.)
OBJECTIVE This study aimed to evaluate ertugliflozin in patients with overweight and obesity with type 2 diabetes mellitus. METHODS Data from three placebo-controlled, randomized, Phase 3 studies were pooled. Patients with baseline BMI ≥ 25 (1,377/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fcfa12aaf948f93d09c4eaa5313315c
http://europepmc.org/articles/PMC7217180
http://europepmc.org/articles/PMC7217180
Autor:
David J. O'connell, Kristy Iglay, Samuel S. Engel, Hakima Hannachi, Lori Moore, Swapnil Rajpathak, Xueying Li
Objective: The objective of this study was to describe the pattern of comorbidities in patients with type 2 diabetes mellitus with and without atherosclerotic cardiovascular disease. Methods: This was a retrospective, cross-sectional analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62bf0384448e5ec472e8abb348e3921
Autor:
Gail Fernandes, Kristy Iglay, Jinan Liu, Alex Z. Fu, Baanie Sawhney, Hakima Hannachi, Annie McNeill, Swapnil Rajpathak, Tongtong Wang
Publikováno v:
Current medical research and opinion. 36(5)
Background: A substantial proportion of patients with type 2 diabetes mellitus (T2DM) do not reach their target HbA1c level on metformin. The objective of this retrospective observational c...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0729eca487f89bc7581d7acd4f9087
https://pubmed.ncbi.nlm.nih.gov/31990206
https://pubmed.ncbi.nlm.nih.gov/31990206
Publikováno v:
Diabetes Therapy
Introduction The use of antihyperglycemic agents (AHA), especially insulin and sulfonylureas (SU), is a risk factor for hypoglycemia. Despite the significant clinical and economic burdens associated with hypoglycemia and the decreasing use of SU in f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee5f3f35e6efaf1b02b597d6dfc7392
https://doi.org/10.1007/s13300-018-0512-3
https://doi.org/10.1007/s13300-018-0512-3
Autor:
Emmanuel Sorbets, Kim A. Eagle, Iris Baumgartner, Deepak L. Bhatt, Gregory Ducrocq, Christopher M. Reid, Hakima Hannachi, David Wu, Philippe Gabriel Steg, Jérémie Abtan, Puneet K. Singhal, Yedid Elbez, Mary E. Hanson
Publikováno v:
Clinical Cardiology
BACKGROUND Patients with symptomatic peripheral artery disease (PAD) are at high risk of ischemic events. However, data about predictors of this risk are limited. HYPOTHESIS We analyzed baseline characteristics and 4-year follow-up of patients enroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d484e16cbd850a9613f697e3c24ece0e
http://europepmc.org/articles/PMC6490387
http://europepmc.org/articles/PMC6490387
Autor:
Kristy Iglay, Swapnil Rajpathak, Manjiri Pawaskar, Hakima Hannachi, Jinan Liu, Samuel S. Engel
Publikováno v:
Current Medical Research and Opinion. 33:1247-1253
Dipeptidyl peptidase-4 (DPP-4) inhibitors have been used for the management of type 2 diabetes (T2D) for over a decade; however, there is a limited understanding of the evolution of their use in the real-world setting over this time period. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3388e946ffd9dda755a00bc9263098e5
https://doi.org/10.1080/03007995.2017.1313211
https://doi.org/10.1080/03007995.2017.1313211
Autor:
Tongtong Wang, Swapnil Rajpathak, Hakima Hannachi, Baanie Sawhney, Gail Fernandes, Kristy Iglay, Ann Marie McNeill
Publikováno v:
Diabetes. 68
Several studies focused on clinical inertia in the U.S. T2D population have demonstrated a significant delay in treatment intensification in real-world clinical practice. The objective of this study was to evaluate if there is a disparity in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::557237e6e162e56fa443b5e5bb713fbc
https://doi.org/10.2337/db19-1496-p
https://doi.org/10.2337/db19-1496-p
Autor:
Gail Fernandes, Kristy Iglay, Hakima Hannachi, Swapnil Rajpathak, Tongtong Wang, Baanie Sawhney, Ann Marie McNeill
Publikováno v:
Diabetes. 68
Previous studies have shown that a large proportion of pts with T2D are not at glycemic target, but the distance to target is not well characterized, including among high risk patients such as those with eCVD/CKD. The objective of the study was to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::971288043c33e7c197fc868da38f3bf6
https://doi.org/10.2337/db19-1495-p
https://doi.org/10.2337/db19-1495-p
Publikováno v:
Diabetes. 68
The recent ADA/EASD consensus statement for management of hyperglycemia preferentially recommends the use of SGLT2i in patients with eCVD or CKD. However, no specific data exist on the level of glycemic control in this high-risk population currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f3d907362032131cdd2efa69317f50
https://doi.org/10.2337/db19-2352-pub
https://doi.org/10.2337/db19-2352-pub
Autor:
Gail Fernandes, Kristy Iglay, Hakima Hannachi, Baanie Sawhney, Tongtong Wang, Swapnil Rajpathak, Ann Marie McNeill
Publikováno v:
Diabetes. 68
Several studies have previously reported “clinical inertia” in the sequential treatment of T2D patients. The objective of the study was to quantify the distance from HbA1c target at the time of treatment intensification among patients failing dua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fc1fb3f9bb5151e56d8888d995778d9
https://doi.org/10.2337/db19-2431-pub
https://doi.org/10.2337/db19-2431-pub